Osaic Holdings
BBC icon

Osaic Holdings’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Osaic Holdings’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
4,463
+3,706
+490% +$165K ﹤0.01% 4297
2026
Q1 		$31.5K Sell
757
-50
-6% -$2.05K ﹤0.01% 5549
2025
Q4 		$31.1K Buy
807
+504
+166% +$17.1K ﹤0.01% 5565
2025
Q3 		$8.27K Hold
303
– – ﹤0.01% 6478
2025
Q2 		$5.86K Buy
+303
New +$5.5K ﹤0.01% 6455
2025
Q1 		– Sell
-447
Closed -$10.7K – 7455
2024
Q4 		$10.7K Hold
447
– – ﹤0.01% 5761
2024
Q3 		$12.5K Hold
447
– – ﹤0.01% 5677
2024
Q2 		$11.3K Hold
447
– – ﹤0.01% 5702
2024
Q1 		$13K Hold
447
– – ﹤0.01% 5607
2023
Q4 		$10.9K Hold
447
– – ﹤0.01% 5790
2023
Q3 		$8.77K Sell
447
-300
-40% -$6.66K ﹤0.01% 5995
2023
Q2 		$17.9K Buy
747
+73
+11% +$1.76K ﹤0.01% 5644
2023
Q1 		$14.8K Hold
674
– – ﹤0.01% 5752
2022
Q4 		$17K Sell
674
-9,660
-93% -$240K ﹤0.01% 5669
2022
Q3 		$253K Buy
10,334
+985
+11% +$25.1K ﹤0.01% 3530
2022
Q2 		$202K Buy
9,349
+6,800
+267% +$149K ﹤0.01% 3784
2022
Q1 		$72K Sell
2,549
-56
-2% -$1.66K ﹤0.01% 4819
2021
Q4 		$101K Sell
2,605
-300
-10% -$12.8K ﹤0.01% 4587
2021
Q3 		$133K Buy
2,905
+70
+2% +$3.27K ﹤0.01% 4275
2021
Q2 		$141K Sell
2,835
-1,568
-36% -$76.7K ﹤0.01% 4188
2021
Q1 		$226K Sell
4,403
-175
-4% -$9.57K ﹤0.01% 3623
2020
Q4 		$227K Sell
4,578
-10,315
-69% -$463K ﹤0.01% 3364
2020
Q3 		$580K Sell
14,893
-447
-3% -$18.2K ﹤0.01% 2303
2020
Q2 		$663K Buy
15,340
+6,719
+78% +$257K ﹤0.01% 2099
2020
Q1 		$253K Buy
+8,621
New +$297K ﹤0.01% 2685

Other funds holding BBC

KCP
Kera Capital Partners San Jose, California $1.04B AUM 52.56% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Osaic Holdings's BBC Position: Q2 2026 in Review

Osaic Holdings increased its Virtus Biotech Clinical Trials ETF (BBC) stake by 490% in Q2 2026, buying an estimated $165K and bringing the position to 4,463 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #4297.

Osaic Holdings first reported a position in BBC in Q1 2020 and has held it in 25 quarters since. The position peaked at $663K in Q2 2020. 20 funds tracked by Wall St. Rank hold BBC as of Q2 2026.

  • Osaic Holdings held 4,463 shares of Virtus Biotech Clinical Trials ETF worth $235K as of Q2 2026.
  • Osaic Holdings bought 3,706 Virtus Biotech Clinical Trials ETF shares in Q2 2026, an estimated $165K.
  • Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4297 holding.
  • Osaic Holdings first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Virtus Biotech Clinical Trials ETF position peaked at $663K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.